Search for Clinical Trial Results
Adenocarcinoma, Follicular - 50 Studies Found
Status | Study |
Terminated |
Study Name: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer Condition:
|
Completed |
Study Name: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer Condition:
|
Not yet recruiting |
Study Name: Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery Condition:
|
Active, not recruiting |
Study Name: Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery Condition:
|
Completed |
Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Condition:
|
Completed |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer Condition:
|
Recruiting |
Study Name: Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers Condition:
|
Active, not recruiting |
Study Name: Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer Condition:
|
Completed |
Study Name: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Condition:
|
Completed |
Study Name: Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer Condition: Head and Neck Cancer Date: 1999-12-10 Interventions:
|